Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Goncagul Celebi"'
Autor:
Cansu Hemsinlioglu, Nil Banu Pelit, Omur Selin Gunaydin, Nihal Ozturk Sahin, Esra Savas Karagacli, Sefa Onur Demir, Evren Safak, Raife Dilek Turan, Goncagul Celebi, Miyase Ezgi Kocaoglu Sen, Zeynep Torun, Utku Seyis, Rehile Zengin, Ayse Sesin Kocagoz, Caglar Cuhadaroglu, Nur Birgen, Siret Ratip, Ercument Ovali
BACKGROUND The efficacy of SARS-CoV2 single donor convalescent plasma (CP) varied according to the application time and the amount of antibody that is administered. Single donor CP has some drawbacks; such as the insufficient levels of neutralizing a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b3286eaecda19042444d50d795e508c
https://doi.org/10.21203/rs.3.rs-1042702/v3
https://doi.org/10.21203/rs.3.rs-1042702/v3
Autor:
Raife Dilek Turan, Omur Selin Gunaydin, Muhammer Elek, Nil Banu Pelit, Ercument Ovali, Sefa Onur Demir, Rehile Zengin, Miyase Ezgi Kocaoglu, Cihan Tastan, Nur Birgen, Nihal Ozturk Sahin, Selen Abanuz, Esra Savas Karagacli, Caglar Cuhadaroglu, Goncagul Celebi, Bulut Yurtsever, Derya Dilek Kancagi, Cansu Hemsinlioglu, Gozde Sir Karakus, Koray Yalcin, Evren Safak, Ayse Sesin Kocagoz, Siret Ratip, Zeynep Torun, Omer Elibol, Didem Cakirsoy, Utku Seyis
Introduction The efficacy of SARS-CoV2 standard single donor convalescent plasma varied according to the application time and most importantly the amount of antibody that is administered. Single donor plasma has some drawbacks; such as the insufficie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10f5eff4215dd3b7996e4caf620d74dc
https://doi.org/10.21203/rs.3.rs-1042702/v1
https://doi.org/10.21203/rs.3.rs-1042702/v1
Autor:
Cansu Hemsinlioglu, Nil Banu Pelit, Koray Yalcin, Omur Selin Gunaydın, Nihal Ozturk Sahin, Esra Savas Karagacli, Omer Elibol, Sefa Onur Demir, Evren Safak, Raife Dilek Turan, Goncagul Celebi, Miyase Ezgi Kocaoglu, Gozde Sir Karakus, Bulut Yurtsever, Cihan Tastan, Selen Abanuz, Didem Cakirsoy, Derya Dilek Kancagi, Zeynep Torun, Utku Seyis, Muhammer Elek, Rehile Zengin, Ayse Sesin Kocagoz, Caglar Cuhadaroglu, Nur Birgen, Siret Ratip, Ercument Ovali
IntroductionThe efficacy of SARS-CoV2 standard single donor convalescent plasma varied according to the application time and most importantly the amount of antibody that is administered. Single donor plasma has some drawbacks; such as the insufficien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19814f32a500e48d0aeba4155ed87953
https://doi.org/10.1101/2021.03.05.21251413
https://doi.org/10.1101/2021.03.05.21251413